ARTEMIS THERAPEUTICS
The Company develops, markets and sells customized authentication solutions designed to enhance the security of documents and branded products, to meet the growing demand for protection from counterfeiting.
ARTEMIS THERAPEUTICS
Industry:
Biotechnology Cyber Security Pharmaceutical Security
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.artemis-therapeutics.com
Status:
Active
Technology used in webpage:
U.S. Server Location Pound Sterling
Similar Organizations
CariDerm Therapeutics
CariDerm Therapeutics is a biopharmaceutical R&D company.
Elios Therapeutics
Elios Therapeutics is a biopharmaceutical company.
Northern Therapeutics
Northern Therapeutics is a biopharmaceutical company
Omnitura Therapeutics
Omnitura Therapeutics is a biopharmaceutical company .
Official Site Inspections
http://www.artemis-therapeutics.com Semrush global rank: 2.18 M Semrush visits lastest month: 9.19 K
- Host name: 104.21.26.29
- IP address: 104.21.26.29
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Artemis Therapeutics"
Artemis Therapeutics Receives Orphan Drug …
Nov 6, 2017 In 2015, malaria caused 212 million clinical episodes and 429,000 deaths, according to the World Health Organization. About Artemis Therapeutics.See details»
Artemis Therapeutics Receives Orphan Drug Designation From …
In 2015, malaria caused 212 million clinical episodes and 429,000 deaths, according to the World Health Organization. About Artemis Therapeutics. Artemis Therapeutics, Inc. is a clinical-stage …See details»
Artemis Therapeutics - Crunchbase Company Profile & Funding
Legal Name Artemis Therapeutics, Inc. Company Type For Profit The Company develops, markets and sells customized authentication solutions designed to enhance the security of …See details»
Artemis Therapeutics, Inc. - LinkedIn
Artemis Therapeutics, Inc. (ATMS) is a biopharmaceutical company developing novel treatments for serious and life-threatening infections. The company’s lead drug candidate, Artemisone, is …See details»
Artemis Therapeutics, Inc. - 1062128 - 2022 - SEC.gov
Incorporation or organization) ... On August 23, 2016, we consummated a merger with Artemis Therapeutics Inc., a Delaware corporation (“Artemis Subsidiary”) and Artemis Acquisition …See details»
Artemis Therapeutics - PitchBook
Artemis Therapeutics was founded in 1997. Where is Artemis Therapeutics headquartered? Artemis Therapeutics is headquartered in New York, NY. What is the size of Artemis …See details»
Artemis Therapeutics, Inc. Company Profile - Dun & Bradstreet
Artemis Therapeutics, Inc. Website. Get a D&B Hoovers Free Trial. Overview Company Description: Don't think it, ink it; InkSure Technologies makes the mark genuine and …See details»
Artemis Therapeutics - Company Profile - Tracxn
Nov 27, 2024 Artemis Therapeutics is developing treatments for life-threatening infections. The company’s lead drug candidate, ATMS-10, a synthetic artemisinin derivative for the treatment …See details»
Artemis Therapeutics | Mindfully Crafted Plant Medicine
Artemis Therapeutics was created as an embrace of the healing properties of nature. And through everything we do and create, we honor magic of daily living, seasonal rhythms, and self care. SHOP. Artemis Therapeutics, LLC. 325 W. …See details»
About - Artemis Therapeutics
Artemis Therapeutics was created as an embrace of the healing properties of nature. And through everything we do and create, we honor magic of daily living, seasonal rhythms, and self care. …See details»
Artemis Therapeutics - Contacts, Employees, Board Members
Artemis Therapeutics is a biopharmaceutical company. Unlock even more features with Crunchbase ProSee details»
FDA grants orphan drug designation to Artemisone by Artemis ...
Nov 16, 2017 Artemisone by Artemis Therapeutics, Inc. (Artemis), a clinical-stage biopharmaceutical company developing new therapies for the treatment of life-threatening …See details»
New Malaria Therapeutic Receives FDA Orphan Drug Designation
Development accelerates for Artemis Therapeutic’s lead anti-viral, anti-parasitic candidate Artemisone. Clinical stage biopharmaceutical Artemis Therapeutics, Inc. announced recently …See details»
Artemis Therapeutics - Crunchbase
Artemis Therapeutics, Northern Therapeutics, Omnitura Therapeutics, Elios Therapeutics, CariDerm Therapeutics, and Kreogene are all part of the biopharmaceutical industry. Northern, …See details»
Artemis Therapeutics Receives Orphan Drug Designation from …
Nov 6, 2017 Artemis Therapeutics announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation for Artemisone, the company's lead product candidate, for …See details»
Artemis Therapeutics Announces Two Recent Publications …
SAN DIEGO /PRNewswire/ -- Artemis Therapeutics, Inc. (OTCQB: ATMS), ("Artemis" or the "Company"), a pharmaceutical company developing new therapies for the treatment of …See details»
Artemisone - Artemis Therapeutics - AdisInsight - Springer
Artemisone, a semi-synthetic 10-alkylaminoartemisinin derivative of artemisinin, was being developed by Artemis Therapeutics, for the treatment of infectiousSee details»
New Data Demonstrate Artemis Therapeutics' Artemisone May Be …
SAN DIEGO, June 7, 2018 /PRNewswire/ -- Artemis Therapeutics, Inc. (OTCQB: ATMS), ("Artemis" or the "Company"), a pharmaceutical company developing new therapies for the …See details»
Eureka
Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative technology platforms that can access cancer-specific targets and harness the …See details»
Eureka Therapeutics Receives Orphan Drug Designations for …
Emeryville, California, February 8, 2022 – Eureka Therapeutics, Inc., a clinical-stage biotechnology company developing novel T-cell therapies to treat solid tumors, today …See details»